FDA Approved: COLESEVELAM HYDROCHLORIDE — Supplemental Application (Cranbury Pharmaceuticals, LLC)

View source ↗

Summary

The FDA approved a supplemental application for Colesevelam hydrochloride (ANDA 209946) submitted by Cranbury Pharmaceuticals, LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypercholesterolemia
• Hyperlipidemia

Drugs mentioned

• Colesevelam hydrochloride (Colesevelam hydrochloride)

Snippet

SUPPL AP for COLESEVELAM HYDROCHLORIDE (COLESEVELAM HYDROCHLORIDE)